BioPharmSignal logoBioPharmSignal

Biotech News

Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01

Greenwich LifeSciences (GLSI)Greenwich LifeSciencesCompany update

GLSI (GLSI) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is glsi.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

GLSIGreenwich LifeSciences2026-07-22 10:00 EST

Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

GLSIGreenwich LifeSciences2026-07-20 10:00 EST

Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01

View all latest news

Greenwich LifeSciences

Greenwich LifeSciences is an immunotherapy company focused on cancer vaccines and breast-cancer treatment. Its story is built around a narrow but potentially differentiated oncology program.

Recent company news

GLSIGreenwich LifeSciences2026-07-22 10:00 EST

Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

GLSIGreenwich LifeSciences2026-07-20 10:00 EST

Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01

GLSIGreenwich LifeSciences2026-07-16 11:30 EST

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01

GLSIGreenwich LifeSciences2026-07-09 10:00 EST

Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01

GLSIGreenwich LifeSciences2026-06-01 12:15 EST

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Stock data

Close
14.24 USD
Market cap
356.53M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States